Anne Marie was diagnosed in the spring of 2006 with invasive lobular breast cancer. Eight rounds of chemo followed (as did a decade of endocrine therapy). That chemo took the toll it too often takes: in her words, “I knew my brain was scrambled [by it]”. She turned to a clinical trial of an intervention designed to help those suffering from chemo brain. She found, though, that the eligibility criteria were so restrictive that she “failed” the trial’s cognitive assessment for entry, scoring higher than the allowed cutoff.